9-PAHSA-d9

9-PAHSA-d9 is the deuterium labeled 9-PAHSA (HY-120657) . 9-PAHSA, an endogenous fatty acid, reduces blood glucose levels and attenuates inflammation[1].

Product Specifications

CAS Number

[1809222-43-2]

UNSPSC

12352211

Hazard Statement

H302-H315-H319-H331-H336-H351-H361-H372

Target

Biochemical Assay Reagents

Type

Isotope-Labeled Compounds

Related Pathways

Others

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Solubility

10 mM in DMSO

Smiles

[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCCCC(OC(CCCCCCCCC)CCCCCCCC(O)=O)=O

Molecular Formula

C34H57D9O4

Molecular Weight

547.94

Precautions

P260-P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

References & Citations

[1]Wang YM, et al. 9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice [published correction appears in Front Pharmacol. 2022 Jan 03;12:827490]. Front Pharmacol. 2021;12:754387. Published 2021 Nov 15.